CardioVascular Research New Brunswick, Saint John Regional Hospital, HHN, Saint John, Canada.
IMPART Investigator Team Canada, Saint John, New Brunswick, Canada.
Curr Hypertens Rep. 2019 Feb 12;21(2):13. doi: 10.1007/s11906-019-0921-3.
The purpose of this review is to discuss the implications of personalized medicine for the treatment of hypertension, including resistant hypertension.
We suggest a framework for the personalized treatment of hypertension based on the concept of a trade-off between simplicity and personalization. This framework is based on treatment strategies classified as low, medium, or high information burden personalization approaches. The extent to which a higher information burden is justified depends on the clinical scenario, particularly the ease with which the blood pressure can be controlled. A one-size-fits-many treatment strategy for hypertension is efficacious for most people; however, a more personalized approach could be useful in patients with subtypes of hypertension that do not respond as expected to treatment. Clinicians seeing patients with unusual hypertension phenotypes should be familiar with emerging trends in personalized treatment of hypertension.
本文讨论了个性化医学对高血压治疗（包括难治性高血压）的影响。
我们根据简单化和个体化之间权衡取舍的概念，提出了一个高血压个体化治疗的框架。该框架基于治疗策略分类，包括低、中、高信息负担的个体化方法。更高的信息负担是否合理取决于临床情况，尤其是血压控制的难易程度。一种适合大多数人的高血压一刀切治疗策略是有效的；然而，对于那些对治疗反应不如预期的高血压亚类患者，更个性化的方法可能会有用。临床医生在治疗不常见的高血压表型患者时，应熟悉高血压个体化治疗的新兴趋势。
